Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
CrossRef Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, doubleblind, multicentre, therapeutic confirmatory phase 3 clinical trial SeungHwan Lee, Kyung Ah Han, EunGyoung Hong, Jun Goo Kang, Choon Hee Chung, Jong Chul Won, Eon Ju Jeon, JungHwan Cho, Ho Chan Cho, Sin Gon Kim, Eun Seok Kang, So Hun Kim, Hae Jin Kim, InKyung Jeong, Sung Wan Chun, Young Min Cho Diabetes, Obesity and Metabolism.2026
Standard subcutaneous protocol (1-2 mg/day): 50mg vial with split reconstitution mix 25 mg at a time to stay inside the 28-day window
A, Faquini IV and Cirne de Azevedo Filho HR (2024) Supratentorial meningeal melanocytoma mimicking meningioma: case report and literature review
Labus J, Woltje K, Stolte KN, Hackel S, Kim KS, Hildmann A, et al
preclinical, not approved
Adipose tissue macrophage-derived exosomes induce ferroptosis via glutathione synthesis inhibition by targeting SLC7A11 in obesity-induced cardiac injury
US$ 26.51
US$ 23.86
US$ 24.17
